Pfizer and other pandemic favorites in focus as FDA’s top vaccine regulator resigns
Pfizer (PFE) and other COVID shot makers such as Moderna (MRNA) will face investor scrutiny as FDA's top vaccine regulator Dr ...
CureVac: Patent Win Notable, But Won't Answer More Fundamental Questions
CureVac N.V. secured funding with GSK amid financial struggles, while a key patent win boosts stock. Click for why my ...
Tucker Carlson is stunned after top doctor reveals REAL cause of America's cancer 'pandemic'
On the latest episode of his podcast, Tucker Carlson was left stunned after cancer researcher Dr Patrick Soon-Shiong revealed ...
MyChesCo on MSN23 小时
Arbutus Biopharma Reports 2024 Financial Results and Strategic Updates
Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced its financial results for the fourth quarter and fiscal year 2024, alongside significant corporate updates. The biotechnology company ...
Investor's Business Daily on MSN19 小时
China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market
That has sparked new demand for the artificial-intelligence-fueled firm, helping Veeva stock close in on a new ...
Hub23 小时
Are We Ready for the Next One?
Five years after COVID-19 reached pandemic status, public health experts reflect on what we learned—and how those lessons can ...
The Tech Edvocate23 小时
Top 100 Scientists in the World
Spread the love Introduction The world of science is vast and ever-evolving, with countless brilliant minds pushing the ...